These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29228470)

  • 21. Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma.
    Margenthaler JA; Meier JD; Virgo KS; Johnson DY; Goshima K; Chan D; Handler BS; Johnson FE
    Am J Surg; 2003 Aug; 186(2):194-200. PubMed ID: 12885617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
    Beaudoux O; Riffaud L; Barbe C; Grange F
    Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.
    Boczar D; Bagaria SP; Spaulding AC; Huayllani MT; Avila FR; Guliyeva G; Lu X; Rinker BD; Forte AJ
    Anticancer Res; 2021 Apr; 41(4):2067-2070. PubMed ID: 33813415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous melanoma in childhood: incidence and prognosis.
    Milton GW; Shaw HM; Thompson JF; McCarthy WH
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S44-8. PubMed ID: 10994472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
    Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
    JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician.
    Martinez JC; Otley CC
    Mayo Clin Proc; 2001 Dec; 76(12):1253-65. PubMed ID: 11761506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.
    Nevins T; Su Y; Doucette S; Kanigsberg N
    J Cutan Med Surg; 2008; 12(6):276-81. PubMed ID: 19317949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma in situ in Puerto Rico: clinical characteristics and detection patterns.
    Muñoz C; Vázquez-Botet M
    P R Health Sci J; 2004 Sep; 23(3):179-82. PubMed ID: 15631171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992.
    Thörn M; Pontén F; Johansson AM; Bergström R
    Cancer Detect Prev; 1998; 22(5):430-7. PubMed ID: 9727624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of melanoma in Japan: a nationwide registry analysis 2011-2013.
    Tomizuka T; Namikawa K; Higashi T
    Melanoma Res; 2017 Oct; 27(5):492-497. PubMed ID: 28609317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive capture of cutaneous melanoma by the Ontario Cancer Registry: validation study using community pathology reports.
    Tran JM; Schwartz R; Fung K; Rochon P; Chan AW
    Cancer Causes Control; 2016 Jan; 27(1):137-42. PubMed ID: 26537120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How are physicians delivering palliative care? A population-based retrospective cohort study describing the mix of generalist and specialist palliative care models in the last year of life.
    Brown CR; Hsu AT; Kendall C; Marshall D; Pereira J; Prentice M; Rice J; Seow HY; Smith GA; Ying I; Tanuseputro P
    Palliat Med; 2018 Sep; 32(8):1334-1343. PubMed ID: 29886804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma: epidemiology, diagnosis, treatment, and outcomes.
    Tuong W; Cheng LS; Armstrong AW
    Dermatol Clin; 2012 Jan; 30(1):113-24, ix. PubMed ID: 22117873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti GL; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Cecchi R; Bottoni U; Bonci A; Scalvenzi M; Giannotti B;
    Arch Dermatol; 2003 May; 139(5):607-12. PubMed ID: 12756097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pterygia are indicators of an increased risk of developing cutaneous melanomas.
    Crewe JM; Threlfall T; Clark A; Sanfilippo PG; Mackey DA
    Br J Ophthalmol; 2018 Apr; 102(4):496-501. PubMed ID: 28844049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
    Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
    Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta-analysis.
    Murchie P; Amalraj Raja E; Brewster DH; Iversen L; Lee AJ
    Eur J Cancer; 2017 Nov; 86():373-384. PubMed ID: 29100192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The debate over diagnostic accuracy in melanoma: dermatologists or general practitioners?
    Grob JJ; Richard MA
    Arch Dermatol; 2002 Sep; 138(9):1251-2. PubMed ID: 12224996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.